Sanofi Singapore operates within the Biotech and Pharmaceuticals industry, focusing on the development and distribution of pharmaceutical products. Founded in 1973 and employing approximately 500 individuals, the company generates revenue of around USD 200 million. Sanofi is committed to corporate social responsibility, as evidenced by its philanthropic initiatives that support not-for-profit organizations and patient advocacy groups. The company evaluates partnerships to ensure alignment with its mission to enhance lives and strengthen communities, maintaining independence from commercial interests. Additionally, Sanofi provides educational resources for healthcare professionals, particularly regarding the use of its products, such as valproate, which is associated with specific risks for certain patient populations. The company emphasizes the importance of thorough communication and guidance for healthcare providers managing patients who may be affected by these medications. Through these efforts, Sanofi seeks to contribute positively to public health and community welfare while adhering to regulatory and ethical standards.